• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素非依赖性前列腺癌小鼠模型中Akt与B-Raf/Erk信号通路的组合活性

Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer.

作者信息

Gao Hui, Ouyang Xuesong, Banach-Petrosky Whitney A, Gerald William L, Shen Michael M, Abate-Shen Cory

机构信息

Center for Advanced Biotechnology and Medicine, Cancer Institute of New Jersey, and Department of Medicine, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, 679 Hoes Lane, Piscataway, NJ 08854, USA.

出版信息

Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14477-82. doi: 10.1073/pnas.0606836103. Epub 2006 Sep 14.

DOI:10.1073/pnas.0606836103
PMID:16973750
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1599986/
Abstract

Androgen independence is responsible for most prostate cancer lethality, yet currently there are no effective clinical treatments. We have been investigating the mechanisms underlying androgen-independent prostate cancer in Nkx3.1;Pten mutant mice, which display salient features of the disease, including a requirement for wild-type androgen receptor (AR) signaling. We now demonstrate that the Akt and Erk MAP kinase signaling pathways are activated in androgen-independent lesions of these mice. Forced activation of either Akt or Erk signaling in an androgen-responsive prostate cancer cell line promotes hormone-independent but AR-dependent growth in culture. Although these pathways act additively in culture, they act synergistically in vivo to promote tumorigenicity and androgen independence in the context of the prostate microenvironment. We propose that androgen independence emerges by means of epithelial-stromal competition, in which activation of Akt and Erk promotes AR activity in the prostate epithelium while counteracting antagonistic effects of the stroma.

摘要

雄激素非依赖性是大多数前列腺癌致死的原因,但目前尚无有效的临床治疗方法。我们一直在研究Nkx3.1;Pten突变小鼠中雄激素非依赖性前列腺癌的潜在机制,这些小鼠表现出该疾病的显著特征,包括对野生型雄激素受体(AR)信号传导的需求。我们现在证明,Akt和Erk MAP激酶信号通路在这些小鼠的雄激素非依赖性病变中被激活。在雄激素反应性前列腺癌细胞系中强制激活Akt或Erk信号传导可促进培养物中激素非依赖性但AR依赖性的生长。尽管这些信号通路在培养中具有累加作用,但它们在体内协同作用,在前列腺微环境中促进肿瘤发生和雄激素非依赖性。我们提出,雄激素非依赖性是通过上皮-基质竞争出现的,其中Akt和Erk的激活促进前列腺上皮中的AR活性,同时抵消基质的拮抗作用。

相似文献

1
Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer.雄激素非依赖性前列腺癌小鼠模型中Akt与B-Raf/Erk信号通路的组合活性
Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14477-82. doi: 10.1073/pnas.0606836103. Epub 2006 Sep 14.
2
Pten inactivation and the emergence of androgen-independent prostate cancer.PTEN失活与雄激素非依赖性前列腺癌的出现。
Cancer Res. 2007 Jul 15;67(14):6535-8. doi: 10.1158/0008-5472.CAN-07-1271.
3
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.RAF/MEK/ERK和PI3K/PTEN/AKT信号通路在恶性转化和耐药中的作用。
Adv Enzyme Regul. 2006;46:249-79. doi: 10.1016/j.advenzreg.2006.01.004. Epub 2006 Jul 18.
4
Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.雄激素依赖性和非依赖性前列腺癌细胞增殖中的信号转导通路
Endocr Relat Cancer. 2005 Mar;12(1):119-34. doi: 10.1677/erc.1.00835.
5
Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.血管活性肠肽通过蛋白激酶A依赖性细胞外信号调节激酶途径在前列腺癌LNCaP细胞中反式激活雄激素受体。
Mol Pharmacol. 2007 Jul;72(1):73-85. doi: 10.1124/mol.107.033894. Epub 2007 Apr 12.
6
An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines.AKT活性阈值调节前列腺癌细胞系中雄激素依赖性和雄激素非依赖性前列腺特异性抗原(PSA)的表达。
Biol Chem. 2008 Jun;389(6):773-80. doi: 10.1515/BC.2008.072.
7
Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase.来源于基质的可溶性因子激活人前列腺LNCaP细胞中的雄激素受体磷酸化:细胞外信号调节激酶/丝裂原活化蛋白激酶的作用
Prostate. 2009 Jun 15;69(9):949-55. doi: 10.1002/pros.20944.
8
Id4 deficiency attenuates prostate development and promotes PIN-like lesions by regulating androgen receptor activity and expression of NKX3.1 and PTEN.Id4基因缺陷通过调节雄激素受体活性以及NKX3.1和PTEN的表达,减弱前列腺发育并促进前列腺上皮内瘤样病变。
Mol Cancer. 2013 Jun 21;12:67. doi: 10.1186/1476-4598-12-67.
9
Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.雄激素受体非基因组信号的变化与LNCaP细胞向雄激素非依赖性的转变相关。
Cancer Res. 2004 Oct 1;64(19):7156-68. doi: 10.1158/0008-5472.CAN-04-1121.
10
Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor.通过AKT与雄激素受体的基因otropic和非基因otropic作用协同作用导致前列腺癌进展。 (注:原文中“genotropic”这个词可能有误,推测可能是“genotropic”,但无法准确翻译这个生僻词,这里保留原文供你参考。)
Proc Natl Acad Sci U S A. 2006 May 16;103(20):7789-94. doi: 10.1073/pnas.0602567103. Epub 2006 May 8.

引用本文的文献

1
Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancer.转移性去势抵抗性前列腺癌中的不良预后基因表达模式
Mol Oncol. 2025 Aug;19(8):2348-2365. doi: 10.1002/1878-0261.70001. Epub 2025 Feb 22.
2
Thiazolidinedione derivatives: emerging role in cancer therapy.噻唑烷二酮衍生物:在癌症治疗中的新作用。
Mol Divers. 2025 Feb 3. doi: 10.1007/s11030-024-11093-3.
3
Claudin-3 Loss of Expression Is a Prognostic Marker in Castration-Resistant Prostate Cancer.Claudin-3 表达缺失是去势抵抗性前列腺癌的预后标志物。
Int J Mol Sci. 2023 Jan 2;24(1):803. doi: 10.3390/ijms24010803.
4
Co-Targeting ErbB Receptors and the PI3K/AKT Axis in Androgen-Independent Taxane-Sensitive and Taxane-Resistant Human Prostate Cancer Cells.在雄激素非依赖性紫杉烷敏感和紫杉烷耐药的人前列腺癌细胞中共同靶向表皮生长因子受体(ErbB)和磷脂酰肌醇-3激酶/蛋白激酶B(PI3K/AKT)轴
Cancers (Basel). 2022 Sep 23;14(19):4626. doi: 10.3390/cancers14194626.
5
Suppressive Effect and Molecular Mechanism of Thunb. Extract against Prostate Carcinogenesis and Castration-Resistant Prostate Cancer.白茅提取物对前列腺癌发生及去势抵抗性前列腺癌的抑制作用及分子机制
Cancers (Basel). 2021 Jul 7;13(14):3403. doi: 10.3390/cancers13143403.
6
Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform.通过新型机器学习平台鉴定循环游离DNA中与转移性前列腺癌疾病进展相关的体细胞基因特征
Oncologist. 2021 Sep;26(9):751-760. doi: 10.1002/onco.13869. Epub 2021 Jul 7.
7
Prostate cancer racial, socioeconomic, geographic disparities: targeting the genomic landscape and splicing events in search for diagnostic, prognostic and therapeutic targets.前列腺癌的种族、社会经济和地理差异:针对基因组格局和剪接事件寻找诊断、预后和治疗靶点。
Am J Cancer Res. 2021 Apr 15;11(4):1012-1030. eCollection 2021.
8
Downregulation of PARVA promotes metastasis by modulating integrin-linked kinase activity and regulating MAPK/ERK and MLC2 signaling in prostate cancer.微小原肌球蛋白α(PARVA)的下调通过调节整合素连接激酶活性以及调控前列腺癌中的丝裂原活化蛋白激酶/细胞外信号调节激酶(MAPK/ERK)和肌球蛋白轻链2(MLC2)信号传导来促进转移。
Transl Androl Urol. 2021 Feb;10(2):915-928. doi: 10.21037/tau-21-108.
9
Signaling Pathways That Control Apoptosis in Prostate Cancer.控制前列腺癌细胞凋亡的信号通路。
Cancers (Basel). 2021 Feb 24;13(5):937. doi: 10.3390/cancers13050937.
10
Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies.非裔美国人中前列腺癌的种族差异与可行的治疗思路和新型免疫疗法。
Cancer Rep (Hoboken). 2021 Oct;4(5):e1340. doi: 10.1002/cnr2.1340. Epub 2021 Feb 17.

本文引用的文献

1
Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer.人原发性前列腺癌中NKX3.1抑癌基因的缺失、甲基化及表达情况
Cancer Res. 2005 Feb 15;65(4):1164-73. doi: 10.1158/0008-5472.CAN-04-2688.
2
Raf-1 expression may influence progression to androgen insensitive prostate cancer.Raf-1的表达可能会影响向雄激素不敏感前列腺癌的进展。
Prostate. 2005 Jun 15;64(1):101-7. doi: 10.1002/pros.20211.
3
Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells.雄激素诱导的人前列腺上皮细胞分化及致瘤性
Cancer Res. 2004 Dec 15;64(24):8867-75. doi: 10.1158/0008-5472.CAN-04-2938.
4
Signal transduction in prostate cancer progression.前列腺癌进展中的信号转导
Clin Sci (Lond). 2005 Apr;108(4):293-308. doi: 10.1042/CS20040329.
5
Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.前列腺癌进展的分子见解:肿瘤微环境的缺失环节
J Urol. 2005 Jan;173(1):10-20. doi: 10.1097/01.ju.0000141582.15218.10.
6
A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis.p27kip1基因剂量在前列腺癌发生小鼠模型中的关键作用。
Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17204-9. doi: 10.1073/pnas.0407693101. Epub 2004 Nov 29.
7
HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability.HER2/neu激酶通过影响DNA结合和稳定性对雄激素受体功能进行依赖性调节。
Cancer Cell. 2004 Nov;6(5):517-27. doi: 10.1016/j.ccr.2004.09.031.
8
Enhanced redundancy in Akt and mitogen-activated protein kinase-induced survival of malignant versus normal prostate epithelial cells.Akt和丝裂原活化蛋白激酶诱导的恶性与正常前列腺上皮细胞存活中的增强冗余。
Cancer Res. 2004 Sep 1;64(17):6190-9. doi: 10.1158/0008-5472.CAN-04-0968.
9
Androgen receptor in prostate cancer.前列腺癌中的雄激素受体。
Endocr Rev. 2004 Apr;25(2):276-308. doi: 10.1210/er.2002-0032.
10
Molecular determinants of resistance to antiandrogen therapy.抗雄激素治疗耐药性的分子决定因素。
Nat Med. 2004 Jan;10(1):33-9. doi: 10.1038/nm972. Epub 2003 Dec 21.